AFM
CYTXZ

Anson Funds Management’s Cytori Therapeutics Inc Series S Warrant CYTXZ Stock Holding History

Anson Funds Management’s Portfolio CYTXZ Stock Details CYTXZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,038,600
Closed -$269K – 51
2019
Q1 		$269K Hold
1,038,600
– – 0.19% 25
2018
Q4 		$301K Hold
1,038,600
– – 0.17% 31
2018
Q3 		$421K Buy
+1,038,600
New +$9.97K 0.15% 13

Other funds holding CYTXZ

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Anson Funds Management's CYTXZ Position: Q2 2019 in Review

Anson Funds Management sold out of Cytori Therapeutics Inc Series S Warrant (CYTXZ) in Q2 2019, closing a stake of 1,038,600 shares — an estimated $269K sold.

Anson Funds Management first reported a position in CYTXZ in Q3 2018 and held it in 3 quarters. The position peaked at $421K in Q3 2018. 5 funds tracked by Wall St. Rank hold CYTXZ as of Q2 2019.

  • Anson Funds Management reported no remaining Cytori Therapeutics Inc Series S Warrant position as of Q2 2019 after selling out during the quarter.
  • Anson Funds Management sold 1,038,600 Cytori Therapeutics Inc Series S Warrant shares in Q2 2019, an estimated $269K.
  • Anson Funds Management first reported a position in Cytori Therapeutics Inc Series S Warrant in Q3 2018 and held it in 3 quarters.
  • Anson Funds Management's Cytori Therapeutics Inc Series S Warrant position peaked at $421K in Q3 2018.
  • 5 funds tracked by Wall St. Rank held Cytori Therapeutics Inc Series S Warrant as of Q2 2019.

Based on Anson Funds Management's 13F filing for Q2 2019, filed 14 Aug 2019.